Yahoo Web Search

Search results

1. • 

     Gradual weaning off anti-obesity jabs could help avoid weight gain – study

     Press Association News via AOL· 4 days ago

     Average weight gain between stopping and restarting the drug was1.3%. Dr Gudbergsen added: “The...

2. • Lexaria (NASDAQ: LEXX) Set to Extend Runway to 2025 Following Warrant Exercise, Issuance

     Digital Journal· 5 days ago

     Begins Dosing of Human Pilot Study No. 2, GLP-1-H24-2 McEwen Mining (NYSE: MUX) (TSX: MUX) Releases...Q1 2024 Results Lexaria (NASDAQ: LEXX) Targeting Massive Type ...

3. • Mullen's (NASDAQ: MULN) Mississippi-Based Facility Receives FTZ Status from U.S. Department of...

     Digital Journal· 5 days ago

     Begins Dosing of Human Pilot Study No. 2, GLP-1-H24-2 McEwen Mining (NYSE: MUX) (TSX: MUX) Releases...Q1 2024 Results Lexaria (NASDAQ: LEXX) Targeting Massive Type ...

4. • SenesTech (NASDAQ: SNES) Anticipates Growth in Product Demand Amid Rising Cases of Human...

     Digital Journal· 6 days ago

     ...Q1 2024 Results Lexaria (NASDAQ: LEXX) Targeting Massive Type 2 Diabetes and Obesity Markets with DehydraTECH(TM) SenesTech's (NASDAQ: SNES...Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs Mullen (NASDAQ: MULN) Inks Agreement with NAFG, Board...

5. • SOBRsafe (NASDAQ: SOBR) Announces New Four-Facility Contract

     Digital Journal· 6 days ago

     ...Q1 2024 Results Lexaria (NASDAQ: LEXX) Targeting Massive Type 2 Diabetes and Obesity Markets with DehydraTECH(TM) SenesTech's (NASDAQ: SNES...Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs Mullen (NASDAQ: MULN) Inks Agreement with NAFG, Board...

6. • Clene (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation Highlights

     Digital Journal· 6 days ago

     ...Q1 2024 Results Lexaria (NASDAQ: LEXX) Targeting Massive Type 2 Diabetes and Obesity Markets with DehydraTECH(TM) SenesTech's (NASDAQ: SNES...Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs Mullen (NASDAQ: MULN) Inks Agreement with NAFG, Board...

7. • Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact...

     Yucaipa News Mirror· 7 days ago

     Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present CAHtalyst™ Adult Phase 3 clinical study baseline characteristics for adults with congenital adrenal hyperplasia ...

8. • Amy-Lynn Albertson: Support local food and local farmers at the Donation Station - Salisbury Post

     The Salisbury Post· 5 days ago

     The Donation Station is a collaboration between N.C. Cooperative Extension and Farmer Foodshare. The program seeks to improve access to fresh, locally-grown food while supporting the farmers ...

9. • How we can bridge the obesity-care gap for Black Americans

     theGrio· 6 days ago

     Today, nearly 108 million American adults are living with obesity, and that number is expected to jump significantly, crossing the 50% threshold by 2030. While that statistic is undoubtedly ...

10. • 

      Commemoration Fund awards latest $1 million to groups supporting underserved, minority communities

      Tulsa World· 5 days ago

      The Commemoration Fund has announced the recipients of its latest round of $1 million in donations...